Loading Events

« All Events

  • This event has passed.

Summit on “Controversies in Precision Medicine: Where do we stand in drug development?”

13/11/2017 - 15/11/2017

Delve into the challenges in Precision Medicine with the inaugural Summit on Controversies in Precision Medicine, which will take place in Berlin, 13-15 November 2017.

  •  Why are the results from genetics-driven precision medicine and systems biology too slow?
  •  Are we getting lost in Big Data?
  • Should there be a stronger role of physiological models and phenotypic data in drug R&D?
  •  How can companies manage their processes and strategies to develop a more agile approach?

The summit, under the leadership of Professor Dan Peer (Director, Tel Aviv University Cancer Biology Research Center), will explore these questions and more, to facilitate discussions on future ways to increase the productivity of biopharmaceutical and clinical innovation.
Be part of 150+ senior level attendees from leading industry companies, academia and government institutions who are putting innovation in their pipeline.

To learn more, click here.
To view the up-to-date programme click here.

Facebook: https://www.facebook.com/Controversies-in-Precision-Medicine-1229066933888688
Twitter: https://twitter.com/PrecisionDrugs
Linkedin: https://www.linkedin.com/company-beta/18109339

Labiotech readers have a 10% additional discount on early bird rates. Don’t wait anymore to get your tickets! Register now here

Want to know more about whose speaking? Here are some articles and interviews by some of the top speakers:

  • Challenges in Precision Medicine by Dan Peer, Director of Tel Aviv University Cancer Biology Research Center

    The top 5 clinical, methodological and regulatory challenges that need to be addressed head on in Precision Medicine are:

    • Lack of disease signatures
    • The low predictive power of animal models
    • Lack of appropriate analytical tools
    • The low predictive power of biomarkers
    • Patents and regulation laws

    Download the full article here.

  • Interview with Dr. Mira Marcus-Kalish, Director, International Research Affairs, Tel-Aviv University Ramat Aviv
    • Be sure to look at the “big picture” as often as you can, on the micro- and macro-environmental features of the human body functioning.
    • Know the challenges: The number of patients/ samples needed, the best fitting analysis tools and thresholds to justify your precise target according to the current statistical and mathematical needs.
    • Find different ways, targeted tools and methodologies to ensure reliability, and replicability.
    • In the pre-processing phase, the cleaning, imputation and the curation of the data and the missing value must be taken care of before using the analysis tool.

    Read and download the full interview here.

  • Q&A with Professor Denis Noble, Oxford University
    • Where do we stand in drug development for precision medicine?
    • What is the greatest challenge at the moment in precision medicine?
    • What is the next step needed in precision medicine for us to actualise its potential?
    • How can academia and industry work together to drive forward this next step?

    Read and download the full interview here.


Event Category:

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and its' freely accessible content.